Submission Details
| 510(k) Number | K971141 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 28, 1997 |
| Decision Date | April 28, 1997 |
| Days to Decision | 31 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K971141 is an FDA 510(k) clearance for the FT4 METHOD FOR THE DIMENSION RXL CLINICAL CHEMISTRY SYSTEM, a Radioimmunoassay, Free Thyroxine (Class II — Special Controls, product code CEC), submitted by Dade Chemistry Systems, Inc. (Newark, US). The FDA issued a Cleared decision on April 28, 1997, 31 days after receiving the submission on March 28, 1997. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1695.
| 510(k) Number | K971141 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 28, 1997 |
| Decision Date | April 28, 1997 |
| Days to Decision | 31 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | CEC — Radioimmunoassay, Free Thyroxine |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1695 |